Dr. Gopaul is the Chief Executive Officer of Nuovotech LLC, a biotech company developing high-quality yet simple, affordable and low maintenance medical devices to meet the needs of low and middle-income countries. He has broad experience in patient care, biomedical research, consulting and entrepreneurship. His particular interests lie in hospital administration, healthcare consulting and biotech start-ups.
He was previously a Research Fellow at the National Institutes of Health where he focused on HIV research, specifically HIV immunology. At the University of Maryland, he was the Doris Duke Translational Malaria Research Fellow where he worked in the evaluation of candidate vaccines and spending weeks in Mali conducting Phase 2 clinical trials on a vaccine candidate. He was previously a Business Consultant with the Rare Genomics Institute where he worked with a team to determine an optimal strategy for the transfer of funds and sharing of intellectual property between the non-profit and a university.
Dr. Gopaul is a resident at Virginia Commonwealth University in Richmond, receiving his medical degree from the University of Maryland School of Medicine. He obtained his Bachelors of Science in Biological Sciences at Howard University graduating Summa Cum Laude with a GPA of 4.0. He holds a Masters degree in Public Health from the Bloomberg School of Public Health at Johns Hopkins University. He also has a Masters in Business Administration from the Carey School of Business at Johns Hopkins.